BIOFORDRUG

Biofordrug is an Italian biotechnology company and a spin-off from the University of Bari Aldo Moro. The company specializes in the design and development of innovative drug delivery systems, particularly focusing on cyclodextrin-based carriers and nanoparticles to improve the bioavailability and targeting of therapeutic agents. Its research primarily targets Central Nervous System (CNS) disorders and oncology, with a specific emphasis on ligands for the Translocator Protein (TSPO). Biofordrug provides R&D services and collaborates with academic and industrial partners to advance early-stage drug candidates from discovery through pre-clinical validation. The company leverages its expertise in medicinal chemistry and nanotechnology to overcome biological barriers such as the blood-brain barrier.